Actionable news
All posts from Actionable news
Actionable news in HZNP: Horizon Pharma, Inc.,

Horizon Pharma: What To Expect From The Q2 Report


Horizon Pharma is slated to report Q2 earnings on August 8, 2016.

The company has a history of solid top- and bottom-line outperformance.

I expect a steady sequential revenue ramp in both the primary care and the orphan segment; Pennsaid 2% and Krystexxa hold the most potential for upside surprises.

FY revenue and EBITDA guidance should stay the same.

The company did not make an acquisition in more than six months; the likelihood of a deal being announced is high over the next few months.

Horizon Pharma (NASDAQ:HZNP)...